Shalini Andersson

Associate Director, Medicinal Chemistry

Senior Director and Head of New Therapeutic Modalities

Associate Director DMPK and Bioanalytical Chemistry

Senior Director Translational Sciences; CVMD ( Interim Head of Dept)

Chief Scientist New Therapeutic Modalities and Head of Oligonucleotide Discovery

Team leader Chiral Chromatography Group

Project Leader and Business Change Lead

Senior Director Drug Metabolism and Pharmacokinetics, CVRM Innovative Medicines Unit

Chief Scientist New Therapeutic Modalities at AstraZeneca

Vice President Oligonucleotide Discovery